Senior Vice President and President, Lilly Diabetes and President, Lilly USA · ELI LILLY & Co (LLY)

Enrique Conterno

A named executive officer of ELI LILLY in every fiscal year CompBrief holds from FY2016 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$4,999,806

Salary $794,683Stock awards $3,057,600

FY2017: $8,624,014

6th of 6 named executive officers at ELI Lilly by FY2018 total.

6 named officers on file for ELI LILLY, FY2018

Enrique Conterno’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing
  • LLY’s disclosed peer group of 35 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ELI LILLY’s whole pay program stands against its peers

  • ELI LILLY’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on LLY→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 22, 2019 (DEF 14A).

Free

Get Enrique Conterno’s full pay file as a PDF — free

More than this page: up to 10 years of Enrique’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Enrique Conterno compensation by year

ELI LILLY Summary Compensation Table · all 3 fiscal years held
In US dollars, as ELI LILLY reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018
Salary$727,960$762,002$794,683
Bonus$0$0$0
Stock awards$2,200,000$6,000,000$3,057,600
Option awards$0$0$0
Non-equity incentive$681,371$816,866$1,099,842
Pension and deferred compensation$935,408$999,426$0
All other$43,678$45,720$47,681
Total$4,588,417$8,624,014$4,999,806

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ELI LILLY & Co DEF 14A filed March 22, 2019, accession 0000059478-19-000146, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ELI LILLY & Co filed document, accession 0000059478-19-000146. Every figure is read from that document and cited to the page and table it appears in. Filed March 22, 2019.

$4.6M
$8.6M
$5.0M
FY16
FY17
FY18
SalaryNon-equity incentiveStock awardsAll other

ELI LILLY’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
David RicksChairman, President, and Chief Executive Officer$17,230,337
Michael HarringtonSenior Vice President and General Counsel$5,440,320
Jeffrey SimmonsPresident, Chief Executive Officer and Director Elanco Animal Health, Inc.$5,379,245
Joshua SmileySenior Vice President and Chief Financial Officer$5,245,343
Daniel SkovronskySenior Vice President and Chief Scientific Officer$5,145,898
Enrique Conterno · this pageSenior Vice President and President, Lilly Diabetes and President, Lilly USA$4,999,806

The full ELI LILLY compensation record

free company brief

This page is one person within ELI LILLY's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the ELI LILLY proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ELI LILLY's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Enrique Conterno's compensation dossier · One-time report. No refunds.